€8bn funding support over 5 years to Supply@Me’s funding platform, with this funding to be delivered across all of the company’s international operations, and the bank co-investing in securitisation notes with institutional investors.
I was a bit unsure here last week reading but since yesterdays news I have to say this is probably going to be my best buy of 2020 and I was 6 figures in AVCT.
I'll keep adding here... I can't imagine how rich I will be at 50p..
I was a bit unsure here last week readin gbut since yesterdays news I have to say this is probably going to be my best buy of 2020 and I was 6 fugures in AVCT.
I'll keep adding here... I can't imagine how rich I will be at 50p..
So anything like a sniff of this possibly being taken to trial... and it will be by by 20's...
*"Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extraordinary B cell activation"
Given the findings of the Atlanta research group, we postulate that Lupuzor ™ may help to reduce or perhaps prevent the occurrence of the cytokine storm seen in Covid-19 patients. Further exploratory work is ongoing to assess Lupuzor's ™ possible potential and clinical program in Covid-19 patients.